Cardiometabolic Disorders News

Prediction models incorporating both cardiovascular disease and fracture risk factors may be able to predict the risk for major adverse CV events in adults with osteoporosis, according to study data.

A subanalysis of the FIDELITY trial showed finerenone reduced risk for all-cause and CV mortality, including sudden cardiac death, compared with placebo in adults with type 2 diabetes and chronic kidney disease.

Adolescents who sleep fewer hours at night had a higher prevalence of overweight and obesity compared with those who slept for the guideline-recommended 8 hours per night, according to a new study.

While statin therapy may cause a small excess of mostly mild muscle pain, most muscle symptoms reported in statin trials were not caused by the drug, according to a meta-analysis presented at the European Society of Cardiology Congress.

In adults with HF with mildly reduced or preserved ejection fraction, dapagliflozin significantly reduced risk for CV death and worsening HF compared with placebo, with no attenuation of treatment benefit for patients with the highest EF.

In the DANCAVAS trial, an invitation for comprehensive imaging-based CV screening did not significantly lower the incidence of all-cause death after 5 years among men aged 65 to 74 years, but results suggest a benefit in men younger than 70.

During the past 2 decades, Endocrine Today has reported on the latest developments in testosterone therapy, including new formulations, debates over indications, and trials assessing risks and benefits for older men.

More adults with type 2 diabetes achieved guideline-recommended strategies for stroke prevention in 2018 compared with 2001, but further improvements are needed, according to study findings published in Diabetes Care.

Green tea extract improved gut health by decreasing inflammation and small intestine permeability in both healthy individuals and those at risk for cardiometabolic disease, according to research in Current Developments in Nutrition.

The Healio and Endocrine Today editors have compiled the most read news from the Endocrine Society annual meeting in June.